Švicarska - njemački - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - interferonum beta-1a adnr - injektionslösung in fertigspritzen - interferonum beta-1a adnr 8.8 µg corresp. 2.4 mio u.i., albuminum humanum, mannitolum, natrii acetas trihydricus, natrii hydroxidum, acidum aceticum, aqua ad iniectabile q.s. ad solutionem pro 0.2 ml corresp. natrium 0.02 mg. - multiple sklerose - biotechnologika

Švicarska - njemački - Swissmedic (Swiss Agency for Therapeutic Products)

target bioscience ag - ibritumomabum tiuxetanum - kit für die herstellung eines radiotherapeutikums - i): ibritumomabum tiuxetanum 3.2 mg, natrii chloridum corresp. natrium 6.9 mg, aqua ad iniectabile q.s. ad solutionem pro 2 ml. ii): natrii acetas trihydricus, natrium 2.3 mg corresp. aqua ad iniectabile q.s. ad solutionem pro 2 ml. iii): albuminum humanum, natrii chloridum, dinatrii phosphas dodecahydricus acidum penteticum, kalii dihydrogenophosphas, kalii chloridum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 33.4 mg. iv): pro usu: i) et ii) et iii) recenter radioactivatum 111-indium ut indii(111-in) trichloridum aut pro usu: i) et ii) et iii) recenter radioactivatum 90-yttrium ut yttrii(90-y) chloridum. - rezidivierendes oder refraktäres indolentes, follikuläres oder transformiertes b-zell non-hodgkin's lyphom; konsolidierungstherapienach remissionsinduktion bei vormals unbehandelten patienten mit follikulärem lymphom stadium iii oder iv - radiopharmazeutika

Švicarska - njemački - Swissmedic (Swiss Agency for Therapeutic Products)

alk-abelló ag - apis melliferae venenum - pricktestlösung - apis melliferae venenum 10 µg, natrii chloridum, phenolum, albuminum seri humani, glycerolum, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, natrii hydroxidum ad ph, acidum hydrochloridum ad ph, aqua ad iniectabile ad solutionem pro 1 ml. - diagnose von allergien des soforttyps - allergen: diagnostikum

Švicarska - njemački - Swissmedic (Swiss Agency for Therapeutic Products)

alk-abelló ag - apis melliferae venenum - pricktestlösung - apis melliferae venenum 100 µg, natrii chloridum, phenolum, albuminum seri humani, glycerolum, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, natrii hydroxidum ad ph, acidum hydrochloridum ad ph, aqua ad iniectabile ad solutionem pro 1 ml. - diagnose von allergien des soforttyps - allergen: diagnostikum

Švicarska - njemački - Swissmedic (Swiss Agency for Therapeutic Products)

alk-abelló ag - apis melliferae venenum - pricktestlösung - apis melliferae venenum 300 µg, natrii chloridum, phenolum, albuminum seri humani, glycerolum, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, natrii hydroxidum ad ph, acidum hydrochloridum ad ph, aqua ad iniectabile ad solutionem pro 1 ml. - diagnose von allergien des soforttyps - allergen: diagnostikum

Švicarska - njemački - Swissmedic (Swiss Agency for Therapeutic Products)

alk-abelló ag - vespulae spp. venenum - pricktestlösung - vespulae spp. venenum 10 µg, natrii chloridum, phenolum, albuminum seri humani, glycerolum, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, natrii hydroxidum ad ph, acidum hydrochloridum ad ph, aqua ad iniectabile ad solutionem pro 1 ml. - diagnose von allergien des soforttyps - allergen: diagnostikum

Švicarska - njemački - Swissmedic (Swiss Agency for Therapeutic Products)

alk-abelló ag - vespulae spp. venenum - pricktestlösung - vespulae spp. venenum 100 µg, natrii chloridum, phenolum, albuminum seri humani, glycerolum, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, natrii hydroxidum ad ph, acidum hydrochloridum ad ph, aqua ad iniectabile ad solutionem pro 1 ml. - diagnose von allergien des soforttyps - allergen: diagnostikum

Švicarska - njemački - Swissmedic (Swiss Agency for Therapeutic Products)

alk-abelló ag - vespulae spp. venenum - pricktestlösung - vespulae spp. venenum 300 µg, natrii chloridum, phenolum, albuminum seri humani, glycerolum, dinatrii phosphas dihydricus, natrii dihydrogenophosphas dihydricus, natrii hydroxidum ad ph, acidum hydrochloridum ad ph, aqua ad iniectabile ad solutionem pro 1 ml. - diagnose von allergien des soforttyps - allergen: diagnostikum

Švicarska - njemački - Swissmedic (Swiss Agency for Therapeutic Products)

b. braun medical ag - autologous cultured chondrocytes (entspricht 0.75 mio zellen/qcm) - transplantatprodukt - autologous cultured chondrocytes (entspricht 0.75 mio zellen/qcm) 8.25 - 44 mio/11 cm², collagenum ex pericardio bovis (matrize), dulbecco's modified eagle medium /f12 (kommerziell hergestelltes medium mit vertraglich vereinbarter rezeptur), folgende komponenten sind enthalten in den 14.8 ml acidum ascorbicum, chondroitini sulfas natricus, insulinum humanum (emp), diboterminum alfa, albuminum seri humani, glucosum, calcii pantothenas, acidum folicum, inositolum, nicotinamidum, pyridoxini hydrochloridum, riboflavinum, thiamini hydrochloridum, acidum (+)-alpha-liponicum, biotinum, ethylis linolenas, cyanocobalaminum hypoxanthin, thymidin, putrescin, alaninum, arginini hydrochloridum, asparaginum monohydricum, acidum glutamicum, cysteini hydrochloridum monohydricum, acidum glutamicum, histidini hydrochloridum monohydricum, isoleucinum , leucin, lysini hydrochloridum, methioninum, phenylalaninum, prolinum, serinum, threoninum, tryptophanum , thyrosin, valinum, cystinum, glycinum, glutaminum, acidum hydroxyethylpi - chirurgische therapie zur biologischen rekonstruktion artikulärer knorpeldefekte, des kniegelenks mittels matrixgekoppelter autologer knorpelzelltransplantation (mact). - transplantat: gewebeprodukt

Švicarska - njemački - Swissmedic (Swiss Agency for Therapeutic Products)

glaxosmithkline ag - haemagglutininum influenzae a (h1n1) (virus stamm a/michigan/45/2015 (h1n1)-like: reassortant virus ivr-180 derived from a/singapore/gp1908/2015), haemagglutininum influenzae a (h3n2) (virus stamm a/hong kong/4801/2014 (h3n2)-like: reassortant virus nymc x-263b ), haemagglutininum influenzae b (virus stamm b/phuket/3073/2013 (yamagata lineage)) - injektionssuspension - haemagglutininum influenzae a (h1n1) (virus stamm a/michigan/45/2015 (h1n1)-like: reassortant virus ivr-180 derived from a/singapore/gp1908/2015) 15 µg, haemagglutininum influenzae a (h3n2) (virus stamm a/hong kong/4801/2014 (h3n2)-like: reassortant virus nymc x-263b ) 15 µg, haemagglutininum influenzae b (virus stamm b/phuket/3073/2013 (yamagata lineage)) 15 µg, haemagglutininum influenzae b (virus stamm b/brisbane/60/2008 (victoria lineage)) 15 µg, polysorbatum 80, octoxinolum-10, natrii chloridum, magnesii chloridum hexahydricum, dinatrii phosphas dodecahydricus, kalii dihydrogenophosphas, kalii chloridum, alfa-tocopheroli hydrogenosuccinas, residui: ovalbuminum max. 0.05 µg, formaldehydum max. 5 µg, natrii desoxycholas max. 65 µg, gentamicini sulfas nihil, hydrocortisonum nihil, aqua ad iniectabilia q.s. ad suspensionem pro 0.5 ml. - aktive immunisierung gegen influenza, ab 36 monaten - impfstoffe